Your Article Summary
See Latest ArticlesMethotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy
Alimentary Pharmacology and Therapeutics, 08/24/06
Babatin, M. A., et al. - Ursodeoxycholic acid is widely used as the standard therapy for the treatment of primary biliary cirrhosis and other cholestatic liver diseases...Conclusions: Methotrexate should be considered as a potential additive treatment for symptomatic primary biliary cirrhosis patients who are incomplete biochemical responders to ursodeoxycholic acid therapy
Related Articles
Statins in Primary Biliary Cirrhosis: Are They Safe
Digestive Diseases and Sciences, 10/05/09
Relevance Score: 81%
CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis
Hepatology, 11/13/09
Relevance Score: 80%
Surveillance and Screening of Primary Sclerosing Cholangitis
Digestive Diseases, 11/09/09
Relevance Score: 79%
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study
Hepatology, 10/13/09
Relevance Score: 79%
Microvascular optical assessment confirms the presence of peripheral autonomic dysfunction in primary biliary cirrhosis
Liver International, 10/07/09
Relevance Score: 79%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/03/09
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09
Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview
Journal of the European Academy of Dermatology and Venereology, 12/03/09